Published July 21, 2023
Hey there, folks! Today, we’re going to delve into a recent study that’s causing a bit of a stir in the CBD world. It seems that CBD-infused liquid products available in the United Kingdom often contain lower percentages of CBD than what’s advertised on the product labels. Intrigued? Let’s dive in!
The Study
Researchers from Loughborough University in England decided to put 29 CBD-infused liquid products, including oils, drinks, and tinctures, under the microscope. They conducted laboratory testing to determine the actual CBD concentrations in these products.
What they found was a bit surprising. It turns out that few products had CBD concentrations within 10% of what was advertised, with most falling below the advertised concentrations. This finding is consistent with several other analyses of CBD-infused products from the United Kingdom, the United States, and other places.
The Implications
The researchers concluded that these findings might indicate poor manufacturing standards or that CBD undergoes degradation in consumer products. This raises concerns about the quality of CBD-containing consumer products and highlights the need for improved regulation of such products.
The Bigger Picture
Analyses of commercially available CBD products in the United States have consistently found that these products vary in quality and potency. They often contain contaminants, adulterants, or elevated levels of heavy metals. Despite these findings, these products remain unregulated by the FDA, which has so far refused to oversee the manufacturing or purity of CBD products.
According to survey data compiled by the National Consumers League, more than eight in ten US voters want greater federal regulatory oversight over the labeling and marketing of commercially available CBD products.
So, there you have it, folks! It seems that not all CBD products are created equal, and it’s essential to be an informed consumer. As the saying goes, “Buyer beware!”
The CBD Blaze Take
This is disappointing but not surprising. It confirms the risks of buying CBD goods in an unregulated market. When businesses aren’t held accountable, inflated claims and quality issues thrive.
I don’t blame consumers who feel cheated or misled. We need consistent standards and transparent CBD testing so buyers can make informed decisions. Companies advertising incorrect potencies must be called out.
While federal foot-dragging continues, states should step up on monitoring CBD product quality and accuracy in labeling. Conscientious companies focused on effective formulations have nothing to fear from fair oversight. It will help distinguish the flowers from the weeds in the CBD space.
For more details on the analysis of CBD levels compared to product labeling, check out the original NORML article at https://norml.org/news/2023/07/20/analysis-cbd-percentages-in-infused-liquid-products-often-lower-than-advertised/.